醉酒后少妇被疯狂内射视频,一本色道久久综合一,在线天堂新版资源www在线下载,中文字幕乱人伦高清视频,中字幕视频在线永久在线观看免费

Archive > Volume 15 Issue 2 > 2023,15(2):181-200. DOI:https://doi.org/10.1016/j.chmed.2023.03.003 Prev Next

中藥通過(guò)調(diào)節(jié)腸道菌群-腸道免疫軸治療潰瘍性結(jié)腸炎

Reviews

Chinese herbal medicines for treating ulcerative colitis via regulating gut microbiota-intestinal immunity axis

  • Article
  • Figures
  • Metrics
  • Preview PDF
  • Reference
  • Related
  • Cited by
  • Materials
    摘要:
    潰瘍性結(jié)腸炎 (UC) 是一種高復(fù)發(fā)率的炎癥性腸病。最近的研究表明，微生物生態(tài)失調(diào)和腸道免疫異常是UC中引發(fā)一系列炎癥反應(yīng)的關(guān)鍵因素。調(diào)節(jié)腸道微生物群-腸道免疫回路被認(rèn)為是緩解UC的關(guān)鍵策略之一。據(jù)報(bào)道，許多中草藥，包括一些單味草藥、中藥配方及其衍生成分，通過(guò)調(diào)節(jié)腸道微生物群和腸道免疫，對(duì)UC具有保護(hù)作用。一些臨床試驗(yàn)結(jié)果令人欣喜。本文主要從調(diào)節(jié)腸道微生物群和腸道免疫等腸道穩(wěn)態(tài)的機(jī)制方面對(duì)中藥治療UC的研究現(xiàn)狀進(jìn)行綜述，并對(duì)已有的臨床試驗(yàn)進(jìn)行了總結(jié)。

    Abstract:
    Ulcerative colitis (UC) is one of types of inflammatory bowel disease with high recurrence. Recent studies have highlighted that microbial dysbiosis as well as abnormal gut immunity are crucial factors that initiate a series of inflammatory responses in the UC. Modulating the gut microbiota-intestinal immunity loop has been suggested as one of key strategies for relieving UC. Many Chinese herbal medicines including some of single herb, herbal formulas and the derived constituents have been reported with protective effect against UC through modulating gut microbiome and intestinal immunity. Some clinical trials have shown promising results. This review thus focused on the current knowledge on using Chinese herbal medicines for treating UC from the mechanism aspects of regulating intestinal homeostasis involving microbiota and gut immunity. The existing clinical trials are also summarized.

    關(guān)鍵詞:
    中草藥;腸道微生物群;炎癥;炎癥性腸病;腸道免疫;潰瘍性結(jié)腸炎

    Keywords:


    Project Supported:
    This study was supported by the grants from the Sichuan Science and Technology Program, China (No. 2023NSFSC0614, 2022YFS0624), grant from Science and Technology Program of Luzhou, China (No. 21CGZHPT0001, 2022-YJY-127), grant from Southwest Medical University, China (No. 2021ZKZD017), and grant from The Open Research Project Program of the State Key Laboratory of Quality Research in Chinese Medicine (University of Macau), China (SKL-QRCM-OP21006).

    Clc Number:

WeChat

Mobile website